BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30978640)

  • 21. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
    Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
    Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
    Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
    Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects.
    Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
    Stem Cell Res; 2019 May; 37():101448. PubMed ID: 31077962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
    Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
    Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.
    Gustavsson N; Marote A; Pomeshchik Y; Russ K; Azevedo C; Chumarina M; Goldwurm S; Collin A; Pinto L; Salgado AJ; Klementieva O; Roybon L; Savchenko E
    Stem Cell Res; 2019 Jan; 34():101373. PubMed ID: 30640063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation.
    Lin CH; Cheng YC; Lin HI; Ho MC; Hsu YH; Wen CH; Ko HW; Lu HE; Huang CY; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():123-127. PubMed ID: 29127874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of an induced pluripotent stem cell line (TRNDi008-A) from a Hunter syndrome patient carrying a hemizygous 208insC mutation in the IDS gene.
    Hong J; Xu M; Li R; Cheng YS; Kouznetsova J; Beers J; Liu C; Zou J; Zheng W
    Stem Cell Res; 2019 May; 37():101451. PubMed ID: 31071499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of two iPSC lines, (ICGi015-A and ICGi015-B), by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease.
    Sharipova DV; Kovalenko VR; Bairamova EM; Vartanova VA; Grigor'eva EV; Vyatkin YV; Khabarova EA; Rzaev DA; Zakian SM; Medvedev SP
    Stem Cell Res; 2019 Dec; 41():101652. PubMed ID: 31733442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene.
    Masneri S; Ferraro RM; Lanzi G; Piovani G; Mori L; Barisani C; Moratto D; Plebani A; Badolato R; Soresina A; Giliani S
    Stem Cell Res; 2019 Dec; 41():101596. PubMed ID: 31669783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of an induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a pathogenic LRP10/c.688C > T(p.Arg230Trp) mutation.
    Wang Y; Wei C; Liu Y; Lu X; Wang W; Song N; Zhang W; Xu J; Zhang W; Han F
    Stem Cell Res; 2024 Jun; 77():103359. PubMed ID: 38460235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration.
    Xie F; Cen Z; Ouyang Z; Wu S; Xiao J; Luo W
    Parkinsonism Relat Disord; 2015 Apr; 21(4):420-2. PubMed ID: 25660576
    [No Abstract]   [Full Text] [Related]  

  • 34. PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models.
    Yeh TH; Liu HF; Chiu CC; Cheng ML; Huang GJ; Huang YC; Liu YC; Huang YZ; Lu CS; Chen YC; Chen HY; Cheng YC
    Exp Neurol; 2021 Dec; 346():113863. PubMed ID: 34520727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of induced pluripotent stem cells from a patient with spinocerebellar ataxia type 3.
    Soong BW; Syu SH; Wen CH; Ko HW; Wu ML; Hsieh PC; Hwang SM; Lu HE
    Stem Cell Res; 2017 Jan; 18():29-32. PubMed ID: 28395798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pluripotent Stem Cell Derived Neurons as In Vitro Models for Studying Autosomal Recessive Parkinson's Disease (ARPD): PLA2G6 and Other Gene Loci.
    Gopurappilly R
    Adv Exp Med Biol; 2021; 1347():115-133. PubMed ID: 33990932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of induced pluripotent stem cells (NIMHi004-A, NIMHi005-A and NIMHi006-A) from healthy individuals of Indian ethnicity with no mutation for Parkinson's disease related genes.
    Jagtap S; Sowmithra ; Yadav R; Pal PK; Datta I
    Stem Cell Res; 2022 Apr; 60():102716. PubMed ID: 35220026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a human induced pluripotent stem cell line (CSC-40) from a Parkinson's disease patient with a PINK1 p.Q456X mutation.
    Russ K; Marote A; Savchenko E; Collin A; Goldwurm S; Pomeshchik Y; Roybon L
    Stem Cell Res; 2018 Mar; 27():61-64. PubMed ID: 29331938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease.
    Lu CS; Lai SC; Wu RM; Weng YH; Huang CL; Chen RS; Chang HC; Wu-Chou YH; Yeh TH
    Am J Med Genet B Neuropsychiatr Genet; 2012 Mar; 159B(2):183-91. PubMed ID: 22213678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of an induced pluripotent stem cell line (GIBHi003-A) from a Parkinson's disease patient with mutant PINK1 (p. I368N).
    Abdul MM; Ibañez DP; Zhao P; Liu H; Zhong X; Li Y; Zhang M; Li W; Li Y; Ward C; Chen S; Wang D; Qin B; Esteban MA; Wang X; Fan W; Luo Z
    Stem Cell Res; 2019 Dec; 41():101607. PubMed ID: 31778937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.